William Goldberg | Chairman of the Board
William Goldberg serves as Chairman of DDC and is the CEO of MediMedia, a provider of patient education and consumer health information, outsourced pharmaceutical sales and marketing support services and comprehensive health management programs. Prior to joining MediMedia, Bill was CEO of Planet Pharmaceuticals, a manufacturer and developer of allergy immunotherapy drugs and multi-channel marketer of related products. Previously, he was President of Morton Grove Pharmaceuticals, a manufacturer of liquid generic pharmaceuticals.
More about Bill Goldberg
Prior to joining that company, Bill held senior management and board positions at Lifecare Holdings, an operator of long term acute care hospitals, and TransHealthcare, an operator of skilled nursing facilities. Earlier in his career, Bill worked with a private equity fund focused on buying, repairing and building underperforming businesses. Bill holds a Bachelor of Arts degree from Brown University and a Masters of Business Administration degree from The Wharton School, University of Pennsylvania.
Adam Pierce | Senior Vice President, Oaktree Capital Management, L.P.
Adam Pierce is a Senior Vice President at Oaktree Capital Management, L.P. Prior to joining Oaktree in 2003, Mr. Pierce served as a Financial Analyst in the Investment Bank at JP Morgan Chase & Co., gaining experience on a range of advisory and financing assignments with a primary focus on the healthcare industry.
More about Adam Pierce
Prior thereto, he worked for Goldman, Sachs & Co. Mr. Pierce received a B.A. degree in Economics with a focus on Business Administration from Vanderbilt University.
Alex Buzik | Principal, MTS Health Investors, LLC
Alex Buzik has more than 10 years of experience in the healthcare sector. At MTS, Mr. Buzik is responsible for sourcing, executing and managing private equity transactions in the healthcare services industry. Prior to joining MTS in 2005, Mr. Buzik worked as a member of the Investment Banking Division at Lehman Brothers, where he focused on mergers and acquisitions as well as capital financings within the healthcare industry.
More about Alex Buzik
Mr. Buzik received his Masters of Business Administration from The Wharton School at the University of Pennsylvania (majoring in Finance and Health Care Management) and his Bachelor of Arts in Biochemistry from Dartmouth College. Mr. Buzik is currently a Director of several of MTS' portfolio companies, including Aerocare Holdings, Inc., DNA Diagnostics Center, Inc. and HealthHelp, LLC. He was formerly a Board Member of Chamberlin Edmonds and Associates, Inc.
Brad Wilsted | Senior Managing Director, Blue Ridge Partners
Brad is a founding Partner and Senior Managing Director at Blue Ridge Partners and leads the firm's Healthcare Practice. Brad has over 20 years experience helping healthcare, life sciences and medical device companies improve business performance and achieve profitable revenue growth.
More about Brad Wilsted
Brad was formerly the Interim CEO of DNA Diagnostics Center and has held various senior executive positions at healthcare, pharmaceutical and technology companies and has served as a Director on several Boards. Brad earned his MBA at the Kellogg Graduate School of Management at Northwestern University. Brad currently resides in Boulder Colorado with his family.
Oliver Moses | Senior Managing Director, MTS Health Partners, LLC
Oliver T. Moses is a Senior Managing Director of MTS Health Investors, LLC; a healthcare-focused private equity fund based in New York, NY. Mr. Moses has spent the last 18 years as a healthcare industry advisor and investor. Prior to joining MTS in early 2006, Mr. Moses was a founding partner of MBF Healthcare Partners. Previously, Mr. Moses was a Director in Merrill Lynch's healthcare investment banking group. He joined Merrill Lynch in 1994 and was responsible for advising leading healthcare companies on mergers, acquisitions, and capital structure strategies.
More about Oliver Moses
During his investment banking career, Mr. Moses raised $6.3 billion for his clients and advised on M&A transactions with an aggregate value of more than $16 billion. Prior to investment banking, Mr. Moses was a securities analyst in Merrill Lynch's equity research department, where he provided coverage of companies in the healthcare services industry. In that role, he was ranked as one of Wall Street's "Up and Comers" by Institutional Investor's All-America Research Team Survey. Mr. Moses holds a Bachelor of Arts degree from Bowdoin College. Mr. Moses is currently director of DNA Diagnostics Center, Inc., HealthHelp, LLC, Novis Pharmaceuticals, LLC and Senior Home Care, Inc.
Peter Vitulli | President & CEO, DDC
Peter Vitulli was appointed President and Chief Executive Officer of DDC in July 2010. He has 35 years experience within the consumer products and healthcare industries in both large corporation and entrepreneurial companies. Prior to DDC, he served as the President and CEO of Sciona, Inc., a pioneering Personal Genetics company that provided customized health and wellness solutions. Before Sciona, he was the President and CEO of Amerifit Nutrition, Inc., a nutritional supplement company focused on women's health.
More about Peter Vitulli
Before that he served as the President and CEO of Everfresh Beverages, a private equity backed juice drink company. He spent the first 16 years of his career at the Quaker Oats Company, most recently as President of the North American Gatorade Business, one of the premier functional food products in the world. During his tenure at Quaker, he worked in several divisions including a two-year tenure in Quaker's United Kingdom subsidiary. Peter received his Bachelor's Degree from Holy Cross College and an MBA from New York University. He currently serves on the Boards of DDC and Woodbury Health Products.